Radhika R. Patel

An orally bioavailable Chk1 inhibitor, CCT244747, sensitizes bladder and head and neck cancer cell lines to radiation.

V. Khoo, A. Thompson, J. Kyula, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Trametinib radiosensitises RAS- and BRAF-mutated melanoma by perturbing cell cycle and inducing senescence.

V. Roulstone, J. Kyula, K. Harrington, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

ATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor Microenvironment

A. Melcher, K. Harrington, A. Sadanandam, 2019, Clinical Cancer Research.

CAN ALGAE DEFEAT COVID-19 VIRUS?

Devanshi Patel, Manan Patel, Radhika R. Patel, 2021 .

PD-1 Blockade Following Isolated Limb Perfusion with Vaccinia Virus Prevents Local and Distant Relapse of Soft-tissue Sarcoma

V. Roulstone, A. Melcher, K. Harrington, 2019, Clinical Cancer Research.

CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based Chemoradiotherapy

S. Bhide, K. Harrington, C. Nutting, 2016, Molecular Cancer Therapeutics.

CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids

M. Gerlinger, K. von Loga, D. Cunningham, 2019, Journal of Immunotherapy for Cancer.

Increasing human monoclonal antibody cloning efficiency with a whole-cell modified immunoglobulin-capture assay (mICA)

C. Pinder, P. Langford, P. McKay, 2023, Frontiers in Immunology.